Chassid Otzem, Epstein Irena, Sharabi-Nov Adi, Pikkel Joseph
Department of Ophthalmology, Ziv Medical Center, Safe 13100, Israel.
Int J Ophthalmol. 2018 Jan 18;11(1):163-165. doi: 10.18240/ijo.2018.01.25. eCollection 2018.
We describe the prevalence and treatment of glaucoma in a Muslim Arab population in Israel. Based on the medical records of 15 122 persons, the overall prevalence of glaucoma was 3.9%. Prevalence rates of primary open angle glaucoma (POAG) and primary angle-closure glaucoma (PACG) were 3.0% and 0.42%, respectively. Prevalence rates of women were 135% that of men considering all types of glaucoma, 143% for POAG, and 96% for PACG. Prostaglandin analogs and beta blockers, alone or combined with carbonic anhydrase inhibitors, were the preferred medications. Of 68 patients who underwent trabeculectomy, 27 (39.7%) required medications, postoperatively, for treatment of glaucoma; following Ex-Press shunt surgery, 3/11 (27.3%) required medications. During the last three years, 16 (1.3%) individuals with POAG were recorded as legally blind as a result of glaucoma.
我们描述了以色列阿拉伯穆斯林人群中青光眼的患病率及治疗情况。基于15122人的病历记录，青光眼的总体患病率为3.9%。原发性开角型青光眼（POAG）和原发性闭角型青光眼（PACG）的患病率分别为3.0%和0.42%。考虑到所有类型的青光眼，女性患病率是男性的135%，POAG为143%，PACG为96%。前列腺素类似物和β受体阻滞剂单独使用或与碳酸酐酶抑制剂联合使用是首选药物。在接受小梁切除术的68例患者中，有27例（39.7%）术后需要药物治疗青光眼；接受Ex-Press分流手术后，11例中有3例（27.3%）需要药物治疗。在过去三年中，有16例（1.3%）POAG患者因青光眼被记录为法定盲人。
